Sickle Cell Anemia: Clinical Trials

1 trial for Sickle Cell Anemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Sickle Cell Anemia: new trials by email Literature Review of Sickle Cell Anemia trials Research Report on Sickle Cell Anemia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
CD3/CD19 depleted leukocytes, CD45RA depleted leukocytes, Hydroxyurea - Sickle Cell Anemia, Beta-thalassemia Major
Phase 1 / Phase 2RecruitingPaul Szabolcs52018-08-022026-08-13

Narrower conditions

Anemia (1)  ·  Anemia, Diamond-Blackfan (1)  ·  Anemia, Sickle Cell (1)  ·  beta-Thalassemia (1)

Broader conditions

Anemia, Aplastic (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Anemia, Hypoplastic, Congenital (1)  ·  Bone Marrow Diseases (1)  ·  Bone Marrow Failure Disorders (1)  ·  Congenital Bone Marrow Failure Syndromes (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemoglobinopathies (1)  ·  Red-Cell Aplasia, Pure (1)  ·  Thalassemia (1)

Interventions

Alemtuzumab (1)  ·  Hydroxyurea (1)  ·  Rituximab (1)  ·  Thiotepa (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)

Sponsors

Paul Szabolcs (1)

Countries

United States (1)

Top investigators

Paul Szabolcs, MD (1)